Scientific articles 29 Apr 2025 Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study The Lancet Global Health
Scientific articles 29 Apr 2025 Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study The Lancet Global Health
News 25 Apr 2025 Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
In the media 23 Apr 2025 Race against time: New treatment for deadly HIV complication enters trials Daily Nation
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Scientific articles 21 Apr 2025 A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan – A landmark trial by the Mycetoma Research Center PLOS Neglected Tropical Diseases
Scientific articles 17 Apr 2025 Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network The Lancet Child & Adolescent Health
In the media 17 Apr 2025 New treatment for deadly HIV-linked meningitis enters phase II trial The Standard
In the media 17 Apr 2025 Un nouveau traitement contre la méningite à cryptocoque, en phase d’essai RTS
In the media 16 Apr 2025 Accord historique à l’OMS sur la préparation et la lutte contre les futures pandémies AFP
In the media 16 Apr 2025 Luz verde para un “histórico” tratado mundial contra pandemias impulsado por la OMS El País
Press releases 29 Jun 2022 DNDi welcomes new PAHO recommendations for the treatment of leishmaniasis in the Americas
Press releases 14 Jun 2022 Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa
Press releases 8 Jun 2022 New WHO treatment guidelines offer hope for people co-infected with visceral leishmaniasis and HIV
Press releases 1 Jun 2022 Thai partners unite with DNDi to improve access to treatments and diagnostics for people with hepatitis C in Thailand
Press releases 18 May 2022 Consortium formed to discover antivirals for COVID-19 receives NIH funding to develop globally accessible treatments for pandemics
Press releases 29 Apr 2022 Ministry of Health, Malaysia and Drugs for Neglected Diseases initiative combine forces to lead the battle against dengue
Press releases 20 Apr 2022 DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue
Press releases 8 Apr 2022 Government of the Principality of Monaco supports DNDi to increase access to improved treatment for children with HIV
Press releases 15 Mar 2022 Pfizer blocking research to generate evidence on optimal use of novel antiviral for COVID-19 patients in low- and middle-income countries
Press releases 28 Feb 2022 ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients
Press releases 25 Feb 2022 Expert consortium begins study in South Africa to develop an optimized treatment for cryptococcal meningitis
Press releases 10 Feb 2022 ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment
Press releases 13 Jan 2022 Germany’s Federal Ministry of Education and Research (BMBF) grants additional funding to six PDPs fighting poverty-related and neglected tropical diseases
Press releases 4 Nov 2021 GHIT Fund expands support for DNDi Chagas disease drug discovery programmes
Press releases 27 Sep 2021 COVID Moonshot funded by COVID-19 Therapeutics Accelerator to rapidly develop a safe, globally accessible and affordable antiviral pill